Le Cannet, France

Veronique Parnet


Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2011-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Veronique Parnet: Innovator in Pharmaceutical and Cosmetic Sciences

Introduction

Veronique Parnet is a distinguished inventor based in Le Cannet, France. She has made significant contributions to the fields of human medicine and cosmetics through her innovative research and development efforts. With a total of two patents to her name, Parnet's work focuses on the development of novel compounds that have the potential to improve health outcomes.

Latest Patents

Parnet's latest patents include groundbreaking work on melanocortin receptor antagonist compounds. These compounds are described in detail, including processes for their preparation and their applications in human medicine and cosmetics. The compounds correspond to a specific general formula and are formulated into compositions for pharmaceutical or cosmetic use. Additionally, she has developed novel 3-phenylpropanoic acid compounds, which are also detailed in her patents. These compounds are designed for use in pharmaceutical compositions for various medical applications, including dermatology and cardiovascular diseases.

Career Highlights

Veronique Parnet is currently associated with Galderma Research & Development, where she continues to push the boundaries of innovation in her field. Her work is characterized by a commitment to improving therapeutic options and enhancing cosmetic formulations.

Collaborations

Throughout her career, Parnet has collaborated with notable colleagues, including Claire Bouix-Peter and Isabelle Carlavan. These collaborations have further enriched her research and contributed to the advancement of her projects.

Conclusion

Veronique Parnet stands out as a prominent inventor in the pharmaceutical and cosmetic industries. Her innovative patents and dedication to research exemplify her commitment to improving health and beauty solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…